| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss | -4,177,423 | -4,331,015 | ||
| Net loss per share of common shares, basic | -0.39 | -0.4 | ||
| Net loss per share of common shares, diluted | -0.39 | -0.4 | ||
| Weighted-average number of common shares outstanding, basic | 10,833,393 | 10,784,725 | ||
| Weighted-average number of common shares outstanding, diluted | 10,833,393 | 10,784,725 | ||
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)